Huimin Chen

Dr. Huimin Chen


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
WZWan Zhang
Wan Zhang
SPShu-Fen Peng
Shu-Fen Peng
LCLi Chen
Li Chen
HCHuimin Chen
Huimin Chen
XCXue-Er Cheng
Xue-Er Cheng
YTYu-Han Tang
Yu-Han Tang
Purpose. Leukocyte telomere length (LTL) is an important biomarker of aging. The oxidative balance score (OBS) is used to assess the oxidative stress‐related exposures of diet and lifestyle. This study is aimed at exploring if the OBS was associated with LTL. Methods. 3220 adults were included in this study from the National Health and Nutrition Examination Survey (NHANES) 1999‐2002. LTL was assayed from leukocyte DNA. Twenty dietary and lifestyle factors were selected to score the OBS. Survey‐based multivariable linear regression was conducted to assess the association between the OBS and log‐transformed LTL. Results. The association between the OBS and log‐transformed LTL was positive in females but not males. For females, compared with the lowest OBS category as a reference, the multivariable‐adjusted beta estimate (95% confidence interval, CI) for the highest OBS category was 0.0701 (0.0205–0.1197) (p for trend < 0.01), and the multivariable‐adjusted beta estimate (95% CI) of the continuous OBS was 0.0039 (0.0014–0.0065). There was also the gender difference in the correlations of the dietary OBS and the lifestyle OBS with log‐transformed LTL. Conclusion. There was a positive association between the OBS and LTL in females. This result suggested that diet and lifestyle might affect LTL by regulating oxidative balance.

4 February 2022 in Nutrients
Verified
Journal Article
Open access
PDF file
HLHongkun Lin
Hongkun Lin
XGXiaoping Guo
Xiaoping Guo
JLJingjing Liu
Jingjing Liu
PLPeiyi Liu
Peiyi Liu
GMGuibin Mei
Guibin Mei
PYPing Yao
Ping Yao
Chronic alcohol consumption retards lipophagy, which contributes to the pathogenesis of liver steatosis. Lipophagy-related Rab7 has been presumed as a crucial regulator in the progression of alcohol liver disease despite elusive mechanisms. More importantly, whether or not hepatoprotective quercetin targets Rab7-associated lipophagy disorder is unknown. Herein, alcoholic fatty liver induced by chronic-plus-single-binge ethanol feeding to male C57BL/6J mice was manifested by hampering autophagosomes formation with lipid droplets and fusion with lysosomes compared with the normal control, which was normalized partially by quercetin. The GST-RILP pulldown assay of Rab7 indicated an improved GTP-Rab7 as the quercetin treatment for ethanol-feeding mice. HepG2 cells transfected with CYP2E1 showed similar lipophagy dysfunction when exposed to ethanol, which was blocked when cells were transfected with siRNA-Rab7 in advance. Ethanol-induced steatosis and autophagic flux disruption were aggravated by the Rab7-specific inhibitor CID1067700 while alleviated by transfecting with the Rab7Wt plasmid, which was visualized by immunofluorescence co-localization analysis and mCherry-GFP-LC3 transfection. Furthermore, TBC1D5, a Rab GTPase-activating protein for the subsequent normal circulation of Rab7, was downregulated after alcohol administration but regained by quercetin. Rab7 circulation retarded by ethanol and corrected by quercetin was further revealed by fluorescence recovery after photobleaching (FRAP). Altogether, quercetin attenuates hepatic steatosis by normalizing ethanol-imposed Rab7 turnover disorders and subsequent lipophagy disturbances, highlighting a novel mechanism and the promising prospect of quercetin-like phytochemicals against the crucial first hit from alcohol.

1 November 2025 in Diabetes & Metabolism Journal
Verified
Journal Article
Open access
HCHuimin Chen
Huimin Chen
CGChao Gao
Chao Gao
LMLi Mo
Li Mo
XYXingzhu Yin
Xingzhu Yin
LCLi Chen
Li Chen
YTYuhan Tang
Yuhan Tang
Background: Interleukin 33 (IL33) drives liver fibrosis, and individuals with type 2 diabetes mellitus are more likely advanced to liver fibrosis. However, the role of IL33 in diabetic liver fibrosis remains unclear, prompting our investigation.Methods: We developed a diabetes model in wild-type, IL33−/−, and suppression of tumorigenicity 2 (ST2−/−, IL33 receptor) mice. Furthermore, wild-type diabetic mice were injected with IL33 neutralizing antibody (αIL33). We also co-cultured human liver endothelial cells and human hepatic stellate cells to identify the role of IL33 in high palmitic acid and high glucose conditions.Results: Hepatic collagen deposition was increased in diabetic mice, which was alleviated by IL33 knockout, ST2 knockout, or administration of αIL33. Also, αIL33 treatment blunted liver sinusoidal endothelial cell (LSEC) dysfunction and inflammation during diabetic liver fibrosis progression. Recombinant IL33 (rIL33) treatment aggravated autophagy disruption in the presence of palm acid and high glucose in LSECs, which was blunted by autophagy agonist rapamycin administration and ERK/MAPK inhibitor PD98059 treatment. Hepatic stellate cell line LX-2 co-cultured with rIL33-pretreated LSECs displayed augmented activation, which was also attenuated by rapamycin or PD98059 pretreated.Conclusion: IL33 drives LSEC dysfunction and promotes diabetic hepatic fibrosis, thus a potential therapeutic target for diabetic liver fibrosis.

22 August 2026 in Med Research
Verified
Journal Article
Open access
LCLi Chen
Li Chen
FCFeipeng Cui
Feipeng Cui
TTTianqi Tan
Tianqi Tan
QWQi Wu
Qi Wu
YZYing Zhao
Ying Zhao
QDQianchun Deng
Qianchun Deng
Adverse mental health‐related characteristics contribute to decreased life expectancy, largely driven by an elevated risk of cardiovascular disease (CVD). Dietary fatty acids influence disease occurrence and progression, yet the associations of polyunsaturated fatty acids (PUFAs) with CVD risk and life expectancy in individuals with adverse mental health‐related characteristics remain unclear. This study focused on individuals with loneliness, anxiety/depression, and neuroticism. In prospective cohort analysis, we found that higher intakes of alpha‐linolenic acid (ALA), stearidonic acid (SDA), eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA) were negatively associated with total CVD risk in individuals with loneliness and anxiety/depression. Target trial emulation analyses further showed that higher EPA and DHA intakes were associated with lower early‐onset CVD risk among participants with loneliness, higher ALA and EPA intakes with lower total CVD risk among those with anxiety/depression, and higher EPA intake with lower early‐onset CVD risk among those with neuroticism. Moreover, higher intakes of n‐3 PUFAs were associated with a gain in life expectancy, ranging from 0.42 to 1.81 years. These findings highlight n‐3 PUFA intake, particularly ALA and EPA, as a dietary factor associated with cardiovascular health and longevity in psychologically vulnerable populations.